Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once Daily
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
A Drug Interaction Study With Albiglutide and Warfarin
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Interaction Study of Albiglutide and Digoxin
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Interaction Study of Simvastatin and Albiglutide
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Foretinib in Patients With Recurrent/Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ofatumumab-based Induction Chemoimmunotherapy in Previously Untreated Patients With CLL/SLL
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Seasonal Influenza Vaccine in Adults
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Protectiveness of the Seasonal Influenza Vaccine for 2010-2011
- Status
- COMPLETED
- Phase
- PHASE2
The Purpose of This Study is to Demonstrate the Safety and Effectiveness of Calcipotriene Foam in Subjects With Scalp and Body Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Foretinib in Combination With Lapatinib in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Pharmacokinetics (PK) of AKT and MEK Combination
- Status
- COMPLETED
- Phase
- PHASE1
A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
- Status
- COMPLETED
- Phase
- PHASE1
Phase I/II Study of Lapatinib in Combination With Paclitaxel as 1L Chemotherapy for ErbB2-positive MBC
- Status
- COMPLETED
- Phase
- PHASE2
Study of a Focal Adhesion Kinase Inhibitor in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)
- Status
- COMPLETED
- Phase
- N/A